- Report
- February 2024
- 70 Pages
Australia
From €4230EUR$4,750USD£3,689GBP
- Report
- February 2024
- 75 Pages
Canada
From €4230EUR$4,750USD£3,689GBP
- Report
- February 2024
- 90 Pages
Europe
From €4230EUR$4,750USD£3,689GBP
- Report
- February 2024
- 90 Pages
Africa, Middle East
From €4230EUR$4,750USD£3,689GBP
- Report
- February 2024
- 120 Pages
Global
From €4230EUR$4,750USD£3,689GBP
- Report
- February 2024
- 70 Pages
Latin America
From €4230EUR$4,750USD£3,689GBP
- Report
- August 2023
- 70 Pages
Europe
From €4230EUR$4,750USD£3,689GBP
- Report
- August 2023
- 112 Pages
North America
From €4230EUR$4,750USD£3,689GBP
- Report
- August 2023
- 90 Pages
North America
From €4230EUR$4,750USD£3,689GBP
- Report
- July 2025
- 200 Pages
India
From €2484EUR$2,789USD£2,166GBP
- Report
- June 2025
- 250 Pages
Canada
From €2484EUR$2,789USD£2,166GBP
- Report
- May 2025
- 300 Pages
Global
From €4407EUR$4,949USD£3,843GBP
- Report
- August 2024
- 150 Pages
Global
From €2484EUR$2,789USD£2,166GBP
- Report
- June 2023
- 120 Pages
Asia Pacific
From €3445EUR$3,869USD£3,004GBP
- Report
- May 2023
- 160 Pages
Global
From €4407EUR$4,949USD£3,843GBP
- Report
- May 2023
- 147 Pages
Global
From €4407EUR$4,949USD£3,843GBP
- Report
- January 2025
- 250 Pages
Global
From €4452EUR$4,999USD£3,882GBP
- Report
- March 2023
- 147 Pages
Global
From €4407EUR$4,949USD£3,843GBP
- Report
- March 2023
- 147 Pages
Global
From €4407EUR$4,949USD£3,843GBP
- Report
- March 2026
- 136 Pages
France
From €3561EUR$3,999USD£3,105GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more